Spectral Medical Provides January Tigris Trial Update
Strong enrollment activity to start 2025146 patients enrolledTORONTO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or ...
GitHub19h
Tabler Icons
A set of 5844 free MIT-licensed high-quality SVG icons for you to use in your web projects. Each icon is designed on a 24x24 grid and a 2px stroke. If you load an icon as an image, you can modify its ...
Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
Pursuant to the transaction with Telix, ImaginAb has retained its lead imaging candidate, CD8 ImmunoPET, which is currently in Phase 2 clinical trials and has been licensed by numerous pharmaceutical ...
Targeted Oncology19d
FDA Clears 225Ac-SSO110 for Phase 1/2 SCLC and Merkel Cell Carcinoma Trial
The agent is being developed together with 68 Ga-SSO120 as part of a theranostic approach for targeted radionuclide therapy. In addition, Ariceum, the developer of 225 Ac-SSO110, has recently ...
C&EN23d
Advances in Preclinical Research of Theranostic Radiopharmaceuticals in Nuclear Medicine
State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection, Collaborative Innovation Center of Radiological Medicine of Jiangsu Higher Education ...
C&EN25d
Exploring the Potential of Nanocarriers for Cancer Immunotherapy: Insights into Mechanism, Nanocarriers, and Regulatory Perspectives
Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric ...
snmjournals.org27d
Dosimetry Software for Theranostic Applications: Current Capabilities and Future Prospects
Journal of Nuclear Medicine January 2025, jnumed.124.268998; DOI: https://doi.org/10.2967/jnumed.124.268998 ...